Maternal Polycystic Ovary Syndrome And Gestational Diabetes Risk In Australia
Polycystic ovary syndrome (PCOS) is one of the most common endocrine conditions affecting people of reproductive age. It can involve irregular ovulation, higher androgen levels, acne, excess facial or body hair, and difficulty conceiving. The condition is also closely linked with insulin resistance, which can influence glucose regulation during pregnancy.
Gestational diabetes mellitus (GDM) develops when pregnancy hormones make it harder for the body to use insulin effectively. When a person begins pregnancy with PCOS-related metabolic risk, the likelihood of abnormal blood glucose is higher. Understanding that connection supports earlier planning, appropriate screening and coordinated maternity care across Australia.
Why PCOS Changes Pregnancy Metabolism
Insulin resistance is central to the relationship between PCOS and GDM. The pancreas may produce more insulin to keep blood glucose within range, but this compensation can become less effective as pregnancy progresses. Placental hormones naturally reduce insulin sensitivity, and the combined effect may push glucose levels above the diagnostic threshold.
The risk is not explained by body weight alone. People with a healthy body mass index can have PCOS-related insulin resistance, while weight gain, a family history of type 2 diabetes, previous GDM and increasing maternal age can add further risk. PCOS phenotypes also vary, so the presence or absence of irregular periods does not reliably predict metabolic health.
Hormonal features may contribute as well. Higher circulating androgens have been associated with impaired glucose handling, although the biological pathways are complex. Fertility treatment, a multiple pregnancy or a history of pregnancy complications can create additional reasons for closer monitoring.
The evidence base is part of a wider perinatal research tradition. The FAOPS 2020 archive reflects the international focus on maternal, fetal and neonatal medicine, including the importance of translating research into practical care. Although the Tokyo congress was cancelled during the COVID-19 pandemic, its subject area remains highly relevant to contemporary obstetric practice.
How Australian Screening Works
Australian maternity services generally offer a 75-gram oral glucose tolerance test (OGTT) between 24 and 28 weeks of pregnancy. The test involves a fasting blood sample, a glucose drink, and further samples after one and two hours. Diagnostic thresholds follow national guidance, while local hospitals and clinicians may differ in how they organise early assessment for people with recognised risk factors.
PCOS is commonly treated as a reason to discuss risk early, particularly when it occurs alongside previous GDM, a close family history of diabetes, a higher weight before pregnancy or signs of impaired glucose regulation. Some services arrange an earlier fasting glucose test or OGTT, followed by repeat screening at 24–28 weeks if the initial result is normal. The exact pathway should be confirmed with the GP, obstetrician, endocrinologist or midwife.
A normal early result does not remove the need for later testing. Insulin resistance often increases during the second and third trimesters, so glucose levels can change after an initial assessment. People who have had bariatric surgery, use medicines affecting glucose metabolism or have other endocrine conditions may need an adapted plan.
Australia’s health system is geographically diverse. A patient in metropolitan Melbourne or western Sydney may have easy access to pathology services and a diabetes educator, while someone in regional Queensland, the Northern Territory or a remote Western Australian community may need telehealth, travel coordination or testing through a smaller hospital. Medicare-funded care, private obstetric services and public maternity pathways can operate differently, making early communication valuable.
Reducing Risk Before And During Pregnancy
Preconception care is an important opportunity to review blood pressure, lipid levels, glucose status, medications, sleep, nutrition and mental health. A GP can assess diabetes risk and arrange tests before conception, while a fertility or reproductive endocrinology team can review ovulation treatment and the safety of current medicines.
Lifestyle support should be practical rather than punitive. Regular movement, resistance exercise where medically suitable, adequate sleep and meals built around fibre-rich carbohydrates, vegetables, protein and unsaturated fats can improve insulin sensitivity. Australian dietary advice may need to fit shift work, supermarket access, cultural food patterns and the cost of fresh produce.
Weight management should be handled sensitively. Rapid weight loss is not required for every person with PCOS, and pregnancy is not the time for restrictive dieting. A modest improvement in metabolic health before conception can be useful, but recommendations should account for fertility goals, eating disorder history and individual clinical circumstances.
Metformin is sometimes used for PCOS, prediabetes or type 2 diabetes, but it is not an automatic prevention treatment for GDM. Decisions about continuing, changing or stopping it should be individualised. No supplement has been proven to replace screening, and products such as inositol should be discussed with a qualified clinician before use during pregnancy.
Managing A Diagnosis Of Gestational Diabetes
A GDM diagnosis does not mean a person has failed or caused the condition. It means pregnancy has revealed that insulin production is not fully meeting the body’s increased demands. Care commonly includes glucose monitoring, nutrition education and activity advice, with medication added when targets are not achieved safely through lifestyle measures.
Targets and monitoring schedules vary according to the treating service. A diabetes educator may explain how to use a glucose meter, when to test and how to interpret patterns rather than isolated readings. Dietitians can help adjust carbohydrate distribution across breakfast, lunch, dinner and snacks without unnecessarily restricting energy.
If medication is needed, insulin remains an established option in pregnancy. Some Australian clinicians also prescribe metformin in selected circumstances after discussing its benefits, limitations and potential passage across the placenta. Treatment should reflect glucose results, fetal growth, gestational age, kidney function and the person’s preferences.
GDM care extends beyond birth. Blood glucose usually improves after delivery, but the future risk of type 2 diabetes remains higher, especially when PCOS is also present. A postpartum glucose assessment, ongoing primary care and periodic diabetes screening are important. Breastfeeding support, sleep assistance and realistic movement goals can help families manage the transition home.
Perinatal teams also benefit from looking beyond glucose alone. Broader neonatal topics, including non-pharmacological neonatal care, show how family-centred support and careful observation shape outcomes after birth. The same principle applies when planning feeding, newborn monitoring and postnatal follow-up after a pregnancy affected by GDM.
Coordinating Care Across Australian Communities
Good care depends on clear handover between the GP, midwife, obstetric team, endocrinologist and diabetes educator. The care plan should record the timing of glucose tests, agreed targets, medication instructions, fetal growth assessments and the postpartum follow-up date. Shared electronic records can help, although patients may still need to carry information when moving between public hospitals, private clinics and pathology providers.
Cultural safety is essential. Aboriginal and Torres Strait Islander families may face barriers linked to distance, transport, institutional trust, service availability and continuity of care. Working with Aboriginal health workers, local community-controlled services and family supports can make screening and education more accessible. Interpreters should be offered when needed, rather than relying on relatives to translate medical information.
For families outside major cities, telehealth can support dietetic consultations and medication review, but it cannot replace every pathology, ultrasound or face-to-face assessment. Services may need to coordinate appointments so that travel to a regional centre is efficient. In parts of Australia, hot weather, seasonal work, flood disruption and limited public transport can affect access to testing and follow-up.
The following comparison summarises how risk and care often differ across key stages. It is a guide for discussion rather than a substitute for local clinical advice.
| Stage | Main Concern With PCOS | Useful Assessment Or Action | Australian Care Consideration |
|---|---|---|---|
| Before conception | Insulin resistance, irregular ovulation and untreated diabetes risk | Review glucose, blood pressure, medicines, weight and fertility plans | Start with a GP; referral pathways differ between public and private services |
| Early pregnancy | Previously unrecognised dysglycaemia | Consider early glucose assessment when risk factors are present | Confirm whether the local service recommends early testing and repeat OGTT |
| 24–28 weeks | Rising placental insulin resistance | Complete the 75 g OGTT even if early results were normal | Arrange pathology access early, especially in regional and remote areas |
| After diagnosis | Hyperglycaemia affecting maternal and fetal health | Use glucose monitoring, nutrition support, activity and medication if required | Diabetes educators and dietitians may be accessed through hospital or community services |
| After birth | Recurrence or progression to type 2 diabetes | Complete postpartum testing and maintain long-term primary care | Record follow-up before discharge and consider Medicare-accessible options |
Practical Priorities For Families And Clinicians
Risk assessment should be specific, respectful and revisited as pregnancy progresses. A PCOS diagnosis is important, but it is one part of a broader clinical picture that includes prior pregnancies, family history, glucose results, medications and social circumstances.
Useful priorities include:
- Arrange a preconception or early-pregnancy review with a GP or maternity clinician.
- Discuss whether early glucose testing is appropriate and schedule the routine 24–28-week OGTT.
- Use sustainable food, movement and sleep strategies rather than restrictive pregnancy diets.
- Ask for a diabetes educator or dietitian when glucose readings remain difficult to manage.
- Include Aboriginal health services, interpreters, telehealth and transport support where relevant.
- Book postpartum diabetes testing and ongoing screening before leaving maternity care.
Families benefit from receiving written information about warning signs, glucose targets, medication use and who to contact outside business hours. Clinicians can improve continuity by explaining why each test is needed and by avoiding assumptions based solely on BMI, age or the appearance of PCOS symptoms.
For Australian maternity services, the most effective approach combines evidence-based screening with flexible delivery. Early identification, culturally safe communication and reliable postnatal follow-up can reduce preventable complications while respecting the different realities of families in Sydney, Hobart, Cairns, Darwin and remote communities alike.
Ask a GP, midwife or obstetrician to document an individual glucose-screening plan, review modifiable risk factors and arrange postpartum follow-up. Timely, coordinated care gives people with PCOS a clearer pathway through pregnancy and helps protect long-term metabolic health.
